↓ Skip to main content

Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications

Overview of attention for article published in Frontiers in Pharmacology, February 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications
Published in
Frontiers in Pharmacology, February 2023
DOI 10.3389/fphar.2023.1088288
Pubmed ID
Authors

Tingting Fang, Congcong Ma, Zhanming Zhang, Luning Sun, Ningning Zheng

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Other 1 9%
Student > Doctoral Student 1 9%
Student > Master 1 9%
Unknown 8 73%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 18%
Nursing and Health Professions 1 9%
Unknown 8 73%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2023.
All research outputs
#16,733,516
of 25,387,668 outputs
Outputs from Frontiers in Pharmacology
#6,387
of 19,728 outputs
Outputs of similar age
#258,334
of 479,178 outputs
Outputs of similar age from Frontiers in Pharmacology
#238
of 941 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,728 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 479,178 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 941 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.